Download Summary
Germany scores slightly above average in terms of Access and Care Coverage, with high access to treatment, including biologics and digital therapeutics. Access to diagnostics is adequate, but FeNO is not reimbursed except for therapy initiation with biologics and also not widely utilised. In terms of Policy Context, Germany demonstrates a relatively high level of implementation of severe asthma guidelines and has guidelines in alignment with international best practices. Germany has the lowest score on Health System Characteristics due to a high average number of days spent in the hospital along with a relatively low number of respiratory specialists.
Data from the Severe Asthma Index revealed the following key insights about severe asthma care in Germany
Provides further insights into how Germany scores across each Index category
Guidelines, strategies, and policies related to the management of severe asthma and health outcomes
50/100
Regulations and practices concerning public payor coverage for and availability of diagnostic and treatment services for severe asthma
65/100
Indicators related to clinical management and economic impact of severe asthma and recording of patient health data
44/100
Information about the health impact of severe asthma and severe asthma comorbidities
73/100
Factors impacting prevention, management, and exacerbations of severe asthma
73/100
Aggregate score across the 5 categories.
58.6/100
Explore how each of the 29 OECD countries scored in the Severe Asthma Index
Select different countries to see how they scored across each of the 5 categories and overall